Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris

Cutis

Volumn 83, Issue 5, 2009, Pages 265-272

  Dhawan, Sunil S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; CLINDAMYCIN;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; GEL; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

ACNE VULGARIS; ADOLESCENT; ADULT; BENZOYL PEROXIDE; CLINDAMYCIN; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE;

EID: 68049109189     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gollnick H, Cunliffe W, Berson D, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(suppl 1): S1-S37.
2. Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. Am J Clin Dermatol. 2004;5:261-265.
3. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin 1 benzoyl peroxide (Duac) and erythromycin 1 zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007;21: 311-319.
4. Del Rosso JQ, Elston DM, Hirschmann J, et al. Summary report from the scientific panel on antibiotic usage in dermatology: usage patterns, management challenges and recommendations. Presented at: Summer Meeting of the American Academy of Dermatology; July 26-30, 2006; San Diego, CA.
5. Bikowski J. Treatment selection and patient education tips to boost compliance in acne therapy. Practical Dermatol. January 2005:46-51.
6. Leyden J, Kaidbey K, Levy SF. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. an in vivo comparative study. Am J Clin Dermatol. 2001; 2:263-266.
7. Cunliffe WJ, Holland KT, Bojar R, et al. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24:1117-1133.
8. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol. 1997;37: 590-595.
9. Duac [package insert]. Coral Gables, FL: Stiefel Laboratories, Inc; 2008.
10. BenzaClin [package insert]. Bridgewater, NJ: sanofiaventis, US, LLC; 2008.
11. Draelos ZD, Callender V, Young C, et al. The effect of vehicle formulation on acne medication tolerability. Cutis. 2008;82:281-284.
12. Koo J. How do you foster medication adherence for better acne vulgaris management? Skinmed. 2003;2:229-233.
13. Renzi C, Picardi A, Abeni D, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol. 2002;138: 337-342.
14. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.